Cargando…
Acute rejection : risk factors, management and complications /
| Clasificación: | Libro Electrónico |
|---|---|
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hauppauge, NY :
Nova Science Publishers, Incorporated,
2012.
|
| Colección: | Immunology and immune system disorders.
Surgery--procedures, complications, and results series. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn961570554 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 160326s2012 nyu ob 001 0 eng d | ||
| 040 | |a AZK |b eng |e rda |e pn |c AZK |d OCLCO |d YDXCP |d N$T |d E7B |d OCLCF |d EBLCP |d LOA |d MERUC |d COCUF |d AGLDB |d ICA |d MOR |d PIFPO |d OCLCQ |d ZCU |d OCL |d U3W |d D6H |d STF |d WRM |d VTS |d NRAMU |d ICG |d INT |d VT2 |d OCLCQ |d WYU |d TKN |d OCLCQ |d DKC |d AU@ |d OCLCQ |d M8D |d OCLCQ |d K6U |d OCLCQ |d AJS |d OCLCO |d OCLCQ |d OCLCO |d TMA |d OCLCQ | ||
| 019 | |a 828140624 |a 923653492 |a 962708945 |a 1065824193 | ||
| 020 | |a 1619423510 | ||
| 020 | |a 9781619423510 | ||
| 020 | |z 9781619423466 |q (hardcover) | ||
| 020 | |z 9781619423510 | ||
| 020 | |z 1619423464 | ||
| 029 | 1 | |a AU@ |b 000051707081 | |
| 029 | 1 | |a DEBBG |b BV041049669 | |
| 029 | 1 | |a DEBBG |b BV043961303 | |
| 029 | 1 | |a DEBBG |b BV044087196 | |
| 029 | 1 | |a DEBSZ |b 481298940 | |
| 029 | 1 | |a NZ1 |b 15492303 | |
| 035 | |a (OCoLC)961570554 |z (OCoLC)828140624 |z (OCoLC)923653492 |z (OCoLC)962708945 |z (OCoLC)1065824193 | ||
| 050 | 4 | |a QR188.8 | |
| 072 | 7 | |a MED |x 085030 |2 bisacsh | |
| 082 | 0 | 4 | |a 617.9/5 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Acute rejection : |b risk factors, management and complications / |c Takumi Kobayashi, Riku Arai, editors. |
| 264 | 1 | |a Hauppauge, NY : |b Nova Science Publishers, Incorporated, |c 2012. | |
| 300 | |a 1 online resource (xi, 197 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Immunology and immune system disorders | |
| 490 | 1 | |a Surgery--procedures, complications, and results | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS -- ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Chapter 1: HLA and Non-HLA Genes Polymorphisms: Susceptibility and Severity in Tunisian Patients with Rheumatoid Arthritis -- Abstract -- 1. Introduction -- 2. Evaluation of Genetic Predisposition to RA -- 2.1. Prevalence of RA -- 2.2. Familial Clustering Studies -- 2.3. Twins Studies -- 3. Identification of Candidate Genes -- 3.1. Linkage Studies | |
| 505 | 8 | |a 3.2. Candidate Gene Association Studies4. Results of Linkage Studies in RA -- 5. HLA Association With RA -- 6. Non HLA Candidate Genes Case-control Studies -- 6.1. Protein Tyrosine Phosphatase Non-Receptor, Type 22 (PTPN22) -- 6.2. Tumor Necrosis Factor Receptor Type 2 (TNF-R2) -- 6.3. Peptidyl Arginine Deiminase 4 (PADI 4) -- 6.4. Fc γ Receptor IIIa (FcγRIIIa) -- 6.5. Interleukin 1 Receptor Antagonist (IL-1Ra) -- 6.6. Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) -- 6.7. Apo-1/Fas (CD95) -- 6.8. Adhesion Molecules -- 7. Patients and Methods | |
| 505 | 8 | |a 7.1. Patients and Controls7.2. Methods -- 7.3. Statistical Methods -- 8. Results -- 8.1. HLA Typing -- a/ DRB1 Genotyping -- b/ DRB1*04 Sub-typing -- 8.2. PTPN22 Genotyping -- 8.3. CTLA-4 Genotyping -- 8.4. Apo-1/Fas Genotyping -- 8.5. FcγR Genotyping -- 8.6. Adhesion Molecules Genotyping -- 8.7. IL1 Family Polymorphisms Genotyping -- a/ IL1α (C/T -889) -- b/ IL1Ra (Intron 2) -- c/ IL1β C/T -511 and C/T +3954 -- 9. Discussion -- Conclusion -- Acknowledgment -- References | |
| 505 | 8 | |a Chapter 2: Mechanisms, Management and Consequences of Acute Cellular and Antibody Mediated Rejection in Solid Organ and Reconstructive TransplantationAbstract -- 1. Acute Rejection -- 2. Kidney Transplantation -- 2.1 The Banff Classification -- 2.2 Acute Antibody-Mediated Rejection in Kidney Transplantation -- 2.3 Acute T-Cell-Mediated Rejection in Kidney Transplantation -- 2.3.1. Steps in TCMR � 3 Signals [12] -- 3. Pancreas Transplantation -- 3.1 The Banff Classification -- 3.2 Acute Antibody-Mediated Rejection in Pancreas Transplantation | |
| 505 | 8 | |a 3.3 Acute T-Cell-Mediated Rejection in Pancreas Transplantation4. Liver Transplantation -- 4.1 Banff Schema for Grading of Liver Allograft Rejection -- 4.2 Acute Antibody-Mediated Rejection in Liver Transplantation -- 4.3 Acute T-Cell-Mediated Rejection in Liver Transplantation -- 5. Intestinal and Multivisceral Transplantation -- 5.2 Acute Antibody-Mediated Rejection in Intestinal Transplantation -- 5.3 Acute T-Cell-Mediated Rejection in Intestinal Transplantation -- 6. Vascularized Composite Allotransplantation | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Graft rejection. | |
| 650 | 0 | |a Transplantation immunology. | |
| 650 | 6 | |a Rejet (Biologie) | |
| 650 | 6 | |a Greffe (Chirurgie) |x Immunologie. | |
| 650 | 7 | |a MEDICAL |x Surgery |x Plastic & Cosmetic. |2 bisacsh | |
| 650 | 7 | |a Graft rejection |2 fast | |
| 650 | 7 | |a Transplantation immunology |2 fast | |
| 776 | 0 | 8 | |i Print version: |z 9781619423466 |z 1619423464 |
| 830 | 0 | |a Immunology and immune system disorders. | |
| 830 | 0 | |a Surgery--procedures, complications, and results series. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3017734 |z Texto completo |
| 936 | |a BATCHLOAD | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3017734 | ||
| 938 | |a ebrary |b EBRY |n ebr10654705 | ||
| 938 | |a EBSCOhost |b EBSC |n 540916 | ||
| 938 | |a YBP Library Services |b YANK |n 7252251 | ||
| 994 | |a 92 |b IZTAP | ||